| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-15 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-14 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-13 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-12 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.33 | 1e-11 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |